Tens of millions of women undergo screening mammography in the U.S. each year, making it one of the most consistent preventive touchpoints in women’s health, and one of the most underleveraged for cardiovascular risk identification. The mammogram has a real opportunity to change that and MagView can support your center in making it a reality.
Breast Arterial Calcification Notice Is Now Law in Maryland
Maryland has become the first state in the U.S. to enact a law requiring mammography providers to inform patients when breast arterial calcifications (BAC) are identified during screening. Under House Bill 1364, which takes effect across the state on October 1, 2026, providers must notify women of this finding.
This is an important step given that BAC may indicate a heightened risk of cardiovascular disease. If the trajectory of other women’s health mandates is any indicator, it won’t be the last state to act. The pattern may look familiar: breast density notification started as a patchwork of state laws before becoming a federal requirement in 2023. We wouldn’t be surprised to see BAC reporting follow a similar path. The reporting requirement around breast arterial calcification (BAC) is the most visible part of a much larger shift: the screening mammogram is no longer a single-disease event.
BAC is a documented signal of cardiovascular risk in women. Research published in Clinical Imaging found that BAC carries meaningful implications for atherosclerotic cardiovascular disease risk in women undergoing routine mammography screening — including associations with lifestyle, reproductive, and cardiovascular determinants that extend well beyond the breast.¹ When it appears on a mammogram and the report doesn’t capture it, the patient and the program miss the most efficient cardiovascular touchpoint in women’s health.
If your center wants to track and act on BAC findings, MagView can help you make that a standardized, consistent process across your entire system.
What This Means for Breast Imaging Centers
Breast imaging centers are naturally positioned at the center of this shift. With more patients coming through the door for routine screening than for almost any other preventive service, the mammogram has become a de facto cardiovascular checkpoint.
That creates a meaningful opportunity. Centers integrating BAC findings into their documentation and navigation pathways become the most efficient outreach point for a population that’s otherwise hard to reach through cardiovascular channels.
The operational reality: your radiologists are already reading these images. Building the workflow around what they’re seeing is the next step.
BAC Reporting Lives Inside MagView
MagView is built for exactly this kind of inflection point — when a regulatory requirement lands and programs need to move quickly without rebuilding from scratch.
BAC reporting is already part of the platform. Your radiologists can document whether BAC is present, that finding flows directly into the report, and MagView can include a dedicated section in your patient letters, all without a separate module or a new license.
A Patient Has BAC. Now What?
Documenting the finding is step one. What happens next is where programs can really differentiate themselves.
When a BAC finding is recorded, MagView can automatically notify or assign a navigator to that patient, trigger a follow-up task or workflow, flag the patient for outreach, and track their follow-up status so nothing falls through the cracks. If a referral to cardiology or a primary care provider is appropriate, that recommendation can be generated directly from within the platform.
In short: the finding doesn’t just live in a report. It becomes an actionable item your team can own, track, and close out in the same way you manage high-risk patients today.
Centers that offer a more complete screening experience, one that surfaces cardiovascular risk alongside breast findings, give patients a reason to stay in their system for follow-up care rather than seeking it elsewhere.
See How It Works
Interested in implementing BAC tracking across your system? Contact your MagView account manager to get started.
References
¹ Assessing breast arterial calcification in mammograms and its implications for atherosclerotic cardiovascular disease risk. Clinical Imaging, 2024. https://www.clinicalimaging.org/article/S0899-7071(24)00059-7/abstract
![shutterstock_1299510538-[Converted]](https://magview.com/wp-content/uploads/2023/05/shutterstock_1299510538-Converted.jpg "monitoring breast density")
